Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
The gut microbiota (GM) has become recognized as a crucial element in preserving human fitness and influencing disease consequences. Commensal and pathogenic gut microorganisms are correlated with pathological progress in atherosclerosis (AS). GM may thus be a promising therapeutic target for AS. Na...
Main Authors: | Bing Deng, Liyu Tao, Yiru Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.997056/full |
Similar Items
-
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
by: Jinpeng Jing, et al.
Published: (2023-09-01) -
Gut Microbiota and Its Metabolites in Atherosclerosis Development
by: Magdalena D. Pieczynska, et al.
Published: (2020-01-01) -
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
by: Chih-Fan Yeh, et al.
Published: (2020-11-01) -
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021-07-01) -
Gut Microbiota in Hypertension and Atherosclerosis: A Review
by: Barbara J. H. Verhaar, et al.
Published: (2020-09-01)